Companion and Complementary Diagnostics-Focus on PD-L1 Expression Assays for PD-1/PD-L1 Checkpoint Inhibitors in Non-Small Cell Lung Cancer

Research output: Contribution to journalReviewpeer-review

  • Maria Hersom
  • Jan T. Jorgensen
Original languageEnglish
JournalTherapeutic Drug Monitoring
Volume40
Issue number1
Pages (from-to)9-16
ISSN0163-4356
DOIs
Publication statusPublished - Feb 2018

    Research areas

  • companion diagnostics, complementary diagnostics, drug-diagnostic codevelopment, PD-L1, immune checkpoint inhibitors, NSCLC, precision medicine

ID: 201198293